about
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under i...
Read More
5.2M
XNAS Volume
High volume+gain today
XNAS 13 May, 2025 5:30 PM (EDT)
Board Meeting
The latest board meeting for Vaxart Inc took place on 13 May 2025, for the purpose of Vaxart Inc First Quarter Earnings Result for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Vaxart Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..